Colgate-Palmolive vs Ambev
Colgate-Palmolive vs Ambev is a page that compares business models, financial performance, and market context between the two companies. It presents neutral information on how each operates and the environments in which they compete. The aim is to inform readers with clear, accessible language, not to advocate any view. Educational content, not financial advice.
Colgate-Palmolive vs Ambev is a page that compares business models, financial performance, and market context between the two companies. It presents neutral information on how each operates and the en...
Why It's Moving
Colgate-Palmolive Raises Dividend Amid Insider Selling and Skin Health Headwinds
- Dividend increased 1.9% to $0.53 quarterly ($2.12 annualized), effective Q2 2026, but dividend payout ratio sits at a high 79.39%, leaving limited cushion if earnings decline
- Q4 beat $0.95 EPS versus $0.91 expected with $5.23 billion revenue (+5.8% YoY), yet the company took a $794 million after-tax goodwill impairment tied to skin health, signaling struggles in that strategic segment
- CFO and other insiders sold approximately 184,683 shares worth $17.5 million last quarter, a timing signal that contradicts the dividend increase and suggests skepticism about near-term stock performance
Ambev Shines as Growth Darling Amid Upward Earnings Revisions and Stellar Sales Outlook
- Earnings estimates for the current year jumped 2.8% over the past month, signaling strong investor confidence in Ambev's profit trajectory well above the 1.1% industry average.
- Sales growth forecast at 13.3% crushes the sector's -0.1% decline, highlighting Ambev's ability to expand revenue in tough conditions.
- Zacks Growth Score of B combined with Rank #2 reflects promising revisions and efficiency, making it a standout for growth-focused portfolios.
Colgate-Palmolive Raises Dividend Amid Insider Selling and Skin Health Headwinds
- Dividend increased 1.9% to $0.53 quarterly ($2.12 annualized), effective Q2 2026, but dividend payout ratio sits at a high 79.39%, leaving limited cushion if earnings decline
- Q4 beat $0.95 EPS versus $0.91 expected with $5.23 billion revenue (+5.8% YoY), yet the company took a $794 million after-tax goodwill impairment tied to skin health, signaling struggles in that strategic segment
- CFO and other insiders sold approximately 184,683 shares worth $17.5 million last quarter, a timing signal that contradicts the dividend increase and suggests skepticism about near-term stock performance
Ambev Shines as Growth Darling Amid Upward Earnings Revisions and Stellar Sales Outlook
- Earnings estimates for the current year jumped 2.8% over the past month, signaling strong investor confidence in Ambev's profit trajectory well above the 1.1% industry average.
- Sales growth forecast at 13.3% crushes the sector's -0.1% decline, highlighting Ambev's ability to expand revenue in tough conditions.
- Zacks Growth Score of B combined with Rank #2 reflects promising revisions and efficiency, making it a standout for growth-focused portfolios.
Investment Analysis
Pros
- Colgate-Palmolive reported revenue growth of 3.31% in 2024, reaching $20.10 billion, indicating steady top-line expansion.
- The company has strong brand diversification across oral care, personal care, home care, and pet nutrition segments, supporting market resilience.
- Colgate-Palmolive maintains a solid dividend yield around 2.7%, offering a consistent income stream for shareholders.
Considerations
- Colgate-Palmolive's stock has shown limited price appreciation over the past year, which may be unattractive for growth-focused investors.
- The company has a relatively high debt-to-equity ratio, which raises concerns about its financial leverage and risk exposure.
- Its price-to-earnings (P/E) ratio near 22 suggests potential overvaluation compared to peers, limiting upside from current levels.
Ambev
ABEV
Pros
- Ambev is a leading beverage company in Latin America with strong market share in beer and soft drinks, benefiting from regional brand loyalty and scale.
- The company has demonstrated growth potential driven by premium product launches and expansion in emerging markets with rising consumer incomes.
- Ambev maintains efficient production and distribution infrastructure, supporting operational margins despite commodity price volatility.
Considerations
- Ambev faces currency volatility risks due to significant exposure to emerging markets with fluctuating exchange rates impacting earnings.
- The company's performance is sensitive to regulation and taxation changes in the alcoholic beverages sector, which can constrain profitability.
- Economic slowdown or reduced consumer spending in key Latin American markets poses demand risks given Ambev's market concentration.
Related Market Insights
Why Familiar Brands Could Be Your Gateway to Stock Market Success
Nervous about investing? Discover how familiar consumer brands like Coca-Cola, PepsiCo & Ambev offer stability, dividends, and an accessible entry point to the stock market. Start with Nemo from £1.
Aimee Silverwood | Financial Analyst
October 13, 2025
Related Market Insights
Why Familiar Brands Could Be Your Gateway to Stock Market Success
Nervous about investing? Discover how familiar consumer brands like Coca-Cola, PepsiCo & Ambev offer stability, dividends, and an accessible entry point to the stock market. Start with Nemo from £1.
Aimee Silverwood | Financial Analyst
October 13, 2025
Colgate-Palmolive (CL) Next Earnings Date
I cannot provide the requested information because the search results provided are for Continental AG (CTTAY), a European automotive and tire manufacturer, not for CL Stock. The query appears to reference a different company entirely. To accurately answer when the next earnings date is for CL Stock, I would need search results specific to that ticker symbol. If you're looking for Continental AG's earnings dates, I can provide that information instead.
Ambev (ABEV) Next Earnings Date
Ambev S.A. (ABEV) is scheduled to report its next earnings on May 5, 2026, covering the Q1 2026 results. The company's earnings report will be released before market open, with consensus expectations for earnings per share around $0.04. Based on historical patterns, Ambev typically reports quarterly earnings in May, August, October, and February. Investors should monitor the company's investor relations website for official confirmation and any updates to the scheduled release date.
Colgate-Palmolive (CL) Next Earnings Date
I cannot provide the requested information because the search results provided are for Continental AG (CTTAY), a European automotive and tire manufacturer, not for CL Stock. The query appears to reference a different company entirely. To accurately answer when the next earnings date is for CL Stock, I would need search results specific to that ticker symbol. If you're looking for Continental AG's earnings dates, I can provide that information instead.
Ambev (ABEV) Next Earnings Date
Ambev S.A. (ABEV) is scheduled to report its next earnings on May 5, 2026, covering the Q1 2026 results. The company's earnings report will be released before market open, with consensus expectations for earnings per share around $0.04. Based on historical patterns, Ambev typically reports quarterly earnings in May, August, October, and February. Investors should monitor the company's investor relations website for official confirmation and any updates to the scheduled release date.
Which Baskets Do They Appear In?
Familiar brands might ease stock market anxiety?
Investing in familiar global brands can make the stock market feel more accessible and understandable for many Brazilians. This basket offers exposure to the US and EU-listed parent companies behind the everyday consumer products found in homes across Brazil.
Published: October 13, 2025
Explore BasketWhich Baskets Do They Appear In?
Familiar brands might ease stock market anxiety?
Investing in familiar global brands can make the stock market feel more accessible and understandable for many Brazilians. This basket offers exposure to the US and EU-listed parent companies behind the everyday consumer products found in homes across Brazil.
Published: October 13, 2025
Explore BasketBuy CL or ABEV in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Comparisons
Colgate-Palmolive vs Kroger
A neutral Colgate-Palmolive vs Kroger stock comparison outlining business models, financial performance and market context to guide research decisions.
Colgate-Palmolive vs Diageo
A neutral, factual comparison of Colgate-Palmolive Co. and Diageo plc, examining business models, recent financial performance, and market context without advocacy.
Colgate-Palmolive vs Kimberly-Clark
Colgate-Palmolive vs Kimberly-Clark compare business models, revenue, profitability, dividends and market position to help readers research each company.